
smartbax raises €4.7 million to advance antibiotic compound
Biotechnology company smartbax has announced it has raised €4.7 million to advance a novel antibiotic compound through preclinical stage. The pre-Series A financing round was led by new investors Anobis Asset and Bayern Kapital, with participation from UnternehmerTUM Funding for Innovators as well as existing investors. … Read More


